{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-079360","form_type":"8-K","ticker":"NVCT","cik":"0001875558","company_name":"Nuvectis Pharma, Inc.","filed_at":"2026-06-30T20:43:15+00:00","discovered_at":"2026-06-30T20:44:00.386565+00:00","generated_at":"2026-06-30T20:44:05.974360+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nuvectis Pharma prices $100M public offering of 5M shares at $20.00 per share","bullets":["Priced underwritten public offering of 5,000,000 shares at $20.00 per share for gross proceeds of $100 million.","Net proceeds expected ~$93 million (or ~$107 million if underwriters' 30-day option for 750,000 additional shares is exercised).","Offering expected to close on July 1, 2026; Cantor Fitzgerald acting as sole book-runner.","Proceeds to fund development of NXP100, NXP200, NXP900 and for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-079360","json":"https://secwatch.observer/filing/0001104659-26-079360.json","markdown":"https://secwatch.observer/filing/0001104659-26-079360.md","text":"https://secwatch.observer/filing/0001104659-26-079360.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926079360/0001104659-26-079360-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926079360/tm2619346d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T20:44:05.974360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}